Doxycycline hyclate
Ended Awarded
- Contract number
- SPE2DR26FX4SK
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $9,160
Award facts
- Contract value 100% obligated
- $9,159.58 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on July 27, 2026, with a ceiling value of $9,159.58, for doxycycline hyclate on a firm fixed-price basis. Place of performance is Conshohocken, Pennsylvania, and the ultimate completion date is July 28, 2026. No set-aside was used. The prime is a wholly owned subsidiary of Cencora, Inc. and holds no SBA certifications.
Quick answers
Who was awarded contract SPE2DR26FX4SK?
SPE2DR26FX4SK was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 27, 2026.
How much is contract SPE2DR26FX4SK worth?
The government has obligated $9,160 on SPE2DR26FX4SK.
Is contract SPE2DR26FX4SK an order under another contract?
Yes. SPE2DR26FX4SK is a delivery order under SPE2DR25D7062, an indefinite delivery contract.
Was contract SPE2DR26FX4SK competed?
The extent of competition for SPE2DR26FX4SK was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award